Lilly Launches Online Training for Patient Advocates

March 25, 2014
PHARM EXEC

Pharmaceutical Executive

An interactive training program designed “to help patient advocates better influence decisions related to access to new medicines” was launched today by Eli Lilly.

An interactive training program designed “to help patient advocates better influence decisions related to access to new medicines” was launched today by Eli Lilly.

eMEET (Medicine Evaluation Educational Training) is designed to help patient advocates “navigate the complex world of medicines development, evaluation and assessment.”

It uses video presentations, animations and exercises to show how patients’ experiences are integrated into scientifically based HTA decisions, with training program modules focused on ‘the journey of a medicine’, ‘an introduction to HTA’, ‘HTA in practice’ and ‘patient advocacy group participation in HTA’.

http://www.meetforpatients.com